Sitemap
January 10, 2019 Articles
Filter by Available Specialty
- ‘Cancer-agnostic’ NTRK inhibitor approval ushers in paradigm of personalized genomics-guided therapeutics
- 2018: A year of enhanced understanding about risk, personalized treatment
- Allergan reports continued focus on eye care business
- Biomarkers, clinical risk factors predict AF
- BLOG: Use social media to build your brand
- Blood flow, perfusion imaging device receives FDA clearance
- Blood test for scleroderma, systemic sclerosis biomarkers launched
- California county wins settlement from Bausch + Lomb over packaging
- Cangrelor appears to benefit patients undergoing PCI
- Checkpoint inhibition and rheumatic events: ‘Many more questions than answers’
- Children often receive inappropriate antibiotics in nonpediatric EDs
- Choosing quality cancer care: The effect of branding
- CMS approves National Dialysis Accreditation Commission for ESRD clinic surveys
- Crestor manages cholesterol elevation during NGM282 NASH therapy
- Empagliflozin protects kidney function in Asian adults with type 2 diabetes
- Energy balance may not halt gestational diabetes
- Exercise interventions during, after cancer treatment benefit some patients more than others
- High-protein diets do not affect GFR in healthy individuals
- Hyponatremia increases fracture risk in diabetes
- In HFrEF, women face poorer quality of life, receive less treatment vs. men
- Lupus associated with higher risk for 16 cancer types
- Microbiome conference highlights role microbiota plays in IBD, IBS, obesity
- Modernized trial eligibility criteria aim to remove comorbidities as a barrier to enrollment
- Nivolumab extends OS in advanced esophageal cancer
- Obesity related to lower urinary tract symptoms
- Optometry must follow neurology’s standard of care in retinal artery obstruction
- Oral HT associated with risk for VTE
- Overdose deaths rise 260% among US women aged 30 to 64 years
- Patella resurfacing with TKA may be more cost-effective vs patellar retention
- PCPs not using patient-reported outcome measures to fullest potential
- Possible mortality risk from paclitaxel-coated devices spurs debate, pauses trials
- Potential human risk associated with increasing prevalence of Lyme in dogs
- PRIME: Sacubitril/valsartan reduces mitral regurgitation
- Repurposing commonly-used drugs may benefit those with serious mental illness
- Self-reported marijuana use linked with increased opioid use after musculoskeletal injury
- Single-infusion rituximab slows RA development in at-risk patients
- Thomas Jefferson to negotiate with Temple for acquisition of Fox Chase Cancer Center
- Top stories in hematology/oncology: Bristol-Myers Squibb acquires Celgene, ASH initiates clinical trials for sickle cell disease therapies
- UCSD researchers get OK from FDA for first trial of IV phage therapy
- VIDEO: Software and apps to improve today’s cataract surgeon
- VIDEO: State of the art of intracameral antibiotics and steroids
- Women with IBD at higher risk for postpartum, new-onset psychiatric disorders
- XDR typhoid infections in 5 US children linked to Pakistan outbreak